We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves First Targeted Treatment for Patients With Bile Duct Cancer

News   Apr 21, 2020 | Original story from the FDA

 
FDA Approves First Targeted Treatment for Patients With Bile Duct Cancer
 
 
Advertisement
 

RELATED ARTICLES

Cells Inside Cells: The Bacteria That Live in Cancer Cells

News

Cancer cells are comfy havens for bacteria. That conclusion arises from a rigorous study of over 1,000 tumor samples of different human cancers, which found bacteria living inside the cells of all the cancer types – from brain to bone to breast cancer – and even identified unique populations of bacteria residing in each type of cancer.

READ MORE

FDA Grants Fast Track Designation to Onvansertib for Second-line Treatment of KRAS-mutated Colorectal Cancer

News

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

READ MORE

A Small Twist in Protein Structure Leads to a Big Reaction

News

Researchers devised a way to modify amide bonds with a twist to their chemical structure that significantly speeds up reactions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE